Plain-English translation of NCT07702292 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
is a new imaging agent designed to help doctors better detect certain cancers by highlighting areas where cancer cells are active. This trial is testing whether this medication, combined with a PET/CT scan, can accurately identify five different types of cancer. Researchers want to see if this new approach helps find cancers more reliably than standard imaging alone.
Standard imaging scans don't always detect all cancers or tell doctors exactly where cancer is growing. This medication targets a protein found in many cancers, which could help doctors spot tumors earlier and plan better treatment.
You likely qualify if…
You likely don't qualify if…
You will have a screening visit where your medical history is reviewed and pregnancy tests are done if needed. At your main study visit, you will receive an injection of the imaging medication and then lie still inside a PET/CT scanner for imaging—similar to a CT scan but more detailed. You will have a brief follow-up phone call a few days later to check on how you're doing. The entire process typically takes a few hours at the imaging center.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
Italy
Netherlands